RYAN SARSFIELD: Open Payments
NPI 1508351669 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 41 payments from 13 companies in 2025. Trend: 2023 $386 · 2024 $763 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $151 |
| Indivior Inc. | 5 | $127 |
| Vanda Pharmaceuticals Inc. | 4 | $118 |
| Alkermes, Inc. | 5 | $112 |
| Supernus Pharmaceuticals, Inc. | 3 | $74 |
| Lundbeck LLC | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Braeburn Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
Products named: Auvelity, REXULTI, SUBLOCADE, ARISTADA, FANAPT, Qelbree, BRIXADI, HETLIOZ.
Industry payments across TN — which companies pay providers there.
